site stats

Bridgebio sec filings

WebMar 29, 2024 · On March 29, 2024, QED Therapeutics, Inc. (“QED”), a subsidiary of BridgeBio Pharma, Inc. (the “Company”), entered into a license and collaboration agreement (the “License and Collaboration Agreement”) with Helsinn Healthcare S.A. (“HHC”) and Helsinn Therapeutics (U.S.), Inc. (“HTU”, collectively with HHC, “Helsinn,” … WebMar 9, 2024 · Primecap Management Co. CA owned 0.69% of BridgeBio Pharma worth $10,315,000 as of its most recent SEC filing. Several other institutional investors and hedge funds have also modified their holdings of the stock. Itau Unibanco Holding S.A. acquired a new position in shares of BridgeBio Pharma in the third quarter worth about $28,000. …

SVB Securities Maintains BridgeBio Pharma (BBIO) Outperform

WebMay 12, 2024 · - BridgeBio is eligible to receive up to $905 million, including an upfront payment of $90 million, and up to $815 million in additional milestone payments and royalties WebMar 29, 2024 · of the Securities Exchange Act of 1934 ... (Date of earliest event reported): March 29, 2024 . BridgeBio Pharma, Inc. (Exact name of registrant as specified in its charter) Delaware : 001-38959 : 84-1850815 ... Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant ... morrowind brallion https://dripordie.com

BridgeBio Pharma Announces Proposed Public Offering of …

Web-Ended quarter with $840.9 million in cash, cash equivalents and marketable securities SAN FRANCISCO, AUGUST 11, 2024 – BridgeBio Pharma, Inc. (Nasdaq: BBIO), a … WebApr 11, 2024 · SEC filings and transcripts for BridgeBio Pharma Inc, including financials, news, proxies, indentures, prospectuses, and credit agreements BridgeBio Pharma Inc … Web11 rows · Apr 7, 2024 · SEC Filings Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2024 2024 2024 2024 2024 2024 morrowind box

8-K - SEC

Category:SVB Securities Maintains BridgeBio Pharma (BBIO) Outperform

Tags:Bridgebio sec filings

Bridgebio sec filings

BridgeBio Pharma Reports Inducement Grants under Nasdaq …

WebApr 11, 2024 · Latest SEC filings for BridgeBio Pharma, Inc. (BBIO). WebMar 6, 2024 · The shares of common stock are being offered by BridgeBio pursuant to an effective shelf registration statement on Form S-3ASR that was previously filed with the U.S. Securities and Exchange ...

Bridgebio sec filings

Did you know?

WebThese reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), … WebApr 14, 2024 · The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, CFO Brian C. Stephenson sold 17,717 shares …

WebApr 8, 2024 · The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. BridgeBio Pharma Stock Performance. BridgeBio's Volatile Week Puts Biotech Stocks Under a Microscope; Shares of NASDAQ BBIO traded up $0.08 during midday trading on Friday, reaching $15.61. The stock had a … WebMar 8, 2024 · The shares of common stock are being offered by BridgeBio pursuant to an effective shelf registration statement on Form S-3ASR (File No. 333-239734) that was previously filed with the U.S ...

WebFeb 23, 2024 · Bridgebio Pharma, Inc. (BBIO) SEC Filing 8-K Material Event for the period ending Tuesday, February 21, 2024 WebMar 17, 2024 · BridgeBio was selected to share an oral presentation and posters on its ongoing Phase 2 trial with 15-month results, including the preliminary design of its pivotal Phase 3 study in patients with ...

WebApr 11, 2024 · BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn and Twitter. BridgeBio Contact: Vikram Bali. …

WebMar 8, 2024 · BridgeBio Pharma, Inc. PALO ALTO, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”), a commercial-stage biopharmaceutical company focused on ... morrowind bretonWebApr 11, 2024 · BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic … morrowind braynas hlervuWebBridgeBio Pharma Inc. SEC filings breakout by MarketWatch. View the BBIO U.S. Securities and Exchange Commission reporting information. morrowind brightnessWebApr 14, 2024 · The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, CFO Brian C. Stephenson sold 17,717 shares of BridgeBio Pharma stock in a ... morrowind breton buildWebMar 23, 2024 · BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced … morrowind brilnosu llarysmorrowind box artWebApr 6, 2024 · As of April 6, 2024, the average one-year price target for BridgeBio Pharma is $26.78. The forecasts range from a low of $18.18 to a high of $33.60. The average price … morrowind bsa